EHI
EXAS

Eagle Health Investments’s Exact Sciences EXAS Stock Holding History

Eagle Health Investments’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-147,750
Closed -$15M – 29
2025
Q4 		$15M Sell
147,750
-123,200
-45% -$9.89M 3.3% 12
2025
Q3 		$14.8M Buy
270,950
+47,200
+21% +$2.36M 3.89% 10
2025
Q2 		$11.9M Sell
223,750
-164,900
-42% -$8.38M 2.93% 14
2025
Q1 		$16.8M Buy
+388,650
New +$19.7M 4.37% 12
2024
Q4 		– Sell
-544,200
Closed -$37.1M – 20
2024
Q3 		$37.1M Hold
544,200
– – 7.02% 6
2024
Q2 		$23M Buy
544,200
+423,200
+350% +$23.3M 4.03% 10
2024
Q1 		$8.36M Buy
+121,000
New +$7.65M 1.55% 20

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Eagle Health Investments's EXAS Position: Q1 2026 in Review

Eagle Health Investments sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 147,750 shares — an estimated $15M sold.

Eagle Health Investments first reported a position in EXAS in Q1 2024 and held it in 7 quarters. The position peaked at $37.1M in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Eagle Health Investments reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Eagle Health Investments sold 147,750 Exact Sciences shares in Q1 2026, an estimated $15M.
  • Eagle Health Investments first reported a position in Exact Sciences in Q1 2024 and held it in 7 quarters.
  • Eagle Health Investments's Exact Sciences position peaked at $37.1M in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Eagle Health Investments's 13F filing for Q1 2026, filed 15 May 2026.